Anna Maria Testi

Summary

Affiliation: University of Rome La Sapienza
Country: Italy

Publications

  1. ncbi request reprint Impact of international collaboration on the prognosis of childhood acute promyelocytic leukemia in Iraq
    Anna Maria Testi
    Division of Hematology, Department of Cellular Biotechnologies and Hematology, University La Sapienza, Rome, Italy
    Haematologica 91:509-12. 2006
  2. ncbi request reprint GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children
    Anna Maria Testi
    Dipartimento di Biotecnologie Cellulari ed Ematologia, Universita La Sapienza, Via Benevento 6, 00161 Rome, Italy
    Blood 106:447-53. 2005
  3. doi request reprint Treatment of children with B-cell non-Hodgkin lymphoma in a low-income country
    Maria Luisa Moleti
    Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
    Pediatr Blood Cancer 56:560-7. 2011
  4. ncbi request reprint CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience
    Maria Luisa Moleti
    Division of Haematology, Department of Cellular Biotechnologies, University La Sapienza, Rome, Italy
    Leuk Lymphoma 48:551-9. 2007
  5. pmc Cytomegalovirus in bone marrow cells correlates with cytomegalovirus in peripheral blood leukocytes
    Angela Capobianchi
    Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
    J Clin Microbiol 52:2183-5. 2014
  6. doi request reprint Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome
    Fiorina Giona
    Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
    Blood 119:2219-27. 2012
  7. doi request reprint Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols
    Massimo Breccia
    Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
    Blood 119:49-54. 2012
  8. ncbi request reprint Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy alone
    Maria Luisa Moleti
    Division of Haematology, Department of Cellular Biotechnologies and Hematology, University La Spienza, Rome, Italy
    Leuk Lymphoma 47:333-6. 2006
  9. ncbi request reprint Trisomy 13 in a patient with common acute lymphoblastic leukemia: description of a case and review of the literature
    Francesca R Spirito
    Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Via Benevento 6, 00161 Rome, Italy
    Cancer Genet Cytogenet 144:69-72. 2003
  10. ncbi request reprint A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group
    Anna Maria Testi
    Dipartimento Biotecnologie Cellulari ed Ematologia, Universita La Sapienza Roma, Italy
    Br J Haematol 118:741-7. 2002

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Impact of international collaboration on the prognosis of childhood acute promyelocytic leukemia in Iraq
    Anna Maria Testi
    Division of Hematology, Department of Cellular Biotechnologies and Hematology, University La Sapienza, Rome, Italy
    Haematologica 91:509-12. 2006
    ..The preliminary encouraging results represent a substantial improvement over the earlier experience in childhood acute promyelocytic leukemia in Iraq...
  2. ncbi request reprint GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children
    Anna Maria Testi
    Dipartimento di Biotecnologie Cellulari ed Ematologia, Universita La Sapienza, Via Benevento 6, 00161 Rome, Italy
    Blood 106:447-53. 2005
    ..A white blood cell (WBC) count at diagnosis of greater than 10 x 10(9)/L had a significant impact on EFS (59% vs 83% at 10 years). These results highlight the efficacy and feasibility of the AIDA protocol in the pediatric APL population...
  3. doi request reprint Treatment of children with B-cell non-Hodgkin lymphoma in a low-income country
    Maria Luisa Moleti
    Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
    Pediatr Blood Cancer 56:560-7. 2011
    ..The purpose was to evaluate the feasibility and efficacy of this intensive therapeutic regimen in a limited resource country...
  4. ncbi request reprint CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience
    Maria Luisa Moleti
    Division of Haematology, Department of Cellular Biotechnologies, University La Sapienza, Rome, Italy
    Leuk Lymphoma 48:551-9. 2007
    ..No late toxicity was registered. In our experience with a median follow-up of 11 years, the NCI 89-C-41 protocol has confirmed its high cure rate in BLL and DLBCL children and adolescents...
  5. pmc Cytomegalovirus in bone marrow cells correlates with cytomegalovirus in peripheral blood leukocytes
    Angela Capobianchi
    Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
    J Clin Microbiol 52:2183-5. 2014
    ..A relationship between CMV infection of PBL and BM cells has been found. ..
  6. doi request reprint Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome
    Fiorina Giona
    Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
    Blood 119:2219-27. 2012
    ..The low complication rate in our population suggests that children with MPD may be managed by tailored approaches...
  7. doi request reprint Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols
    Massimo Breccia
    Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
    Blood 119:49-54. 2012
    ..99, in overweight/obese vs under/normal weight patients, P = .049). An increased BMI at diagnosis is associated with a higher risk of developing differentiation syndrome and disease relapse in APL patients treated with AIDA protocols...
  8. ncbi request reprint Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy alone
    Maria Luisa Moleti
    Division of Haematology, Department of Cellular Biotechnologies and Hematology, University La Spienza, Rome, Italy
    Leuk Lymphoma 47:333-6. 2006
    ..The patient remains in complete clinical, immunological and molecular remission and in good clinical conditions 48 months after diagnosis and 40 months after stopping therapy...
  9. ncbi request reprint Trisomy 13 in a patient with common acute lymphoblastic leukemia: description of a case and review of the literature
    Francesca R Spirito
    Dipartimento di Biotecnologie Cellulari ed Ematologia, University La Sapienza, Via Benevento 6, 00161 Rome, Italy
    Cancer Genet Cytogenet 144:69-72. 2003
    ..This report indicates that trisomy 13 can be found also in B-lineage ALL and underlines that this cytogenetic abnormality may identify a subgroup of male patients with clonal evolution potential and an adverse clinical outcome...
  10. ncbi request reprint A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group
    Anna Maria Testi
    Dipartimento Biotecnologie Cellulari ed Ematologia, Universita La Sapienza Roma, Italy
    Br J Haematol 118:741-7. 2002
    ..At 4 years, 39 out of 100 children remain alive, with 27 of them free of leukaemia. This induction therapy has shown antileukaemic efficacy with acceptable toxicity; moreover, all responders proved eligible for intensive consolidation...
  11. doi request reprint Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia
    Anna Paola Iori
    Department of Hematology, Azienda Policlinico Umberto I, Sapienza University, Rome, Italy
    Ann Hematol 91:941-8. 2012
    ..The simultaneous search for CB and UD increases the likelihood of performing a timely transplant...
  12. doi request reprint Autoimmune hemolytic anemia and immune thrombocytopenia as unusual presentations of childhood Hodgkin lymphoma: a case report and review of the literature
    Valerio Cecinati
    Department of Cellular Biotechnologies and Hematology, Division of Hematology, Rome, Italy
    J Pediatr Hematol Oncol 34:280-2. 2012
    ..The identification of this clinical picture as a possible complication of an underlying Hodgkin lymphoma presents difficulties in diagnosis and management of the primary condition...
  13. ncbi request reprint Autoimmune hemolytic anemia in childhood: serologic features in 100 cases
    Stefania Vaglio
    Blood Bank, La Sapienza University II Faculty of Medicine, Rome, Italy
    Transfusion 47:50-4. 2007
    ..The objective of this study was to stress the importance of an appropriate serologic diagnosis in suspected cases...
  14. doi request reprint Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy
    Maurizio Arico
    Pediatric Hematology Oncology, Ospedale dei Bambini G Di Cristina, Palermo, Italy
    J Clin Oncol 26:283-9. 2008
    ..The prognostic value of DNA index was explored in this setting...
  15. ncbi request reprint Outcome of very late relapse in children with acute lymphoblastic leukemia
    Carmelo Rizzari
    Pediatric Department of Monza, Italy
    Haematologica 89:427-34. 2004
    ..The present study was aimed at investigating clinical features and treatment outcome of children with very late relapse, diagnosed and treated in Italy in the last 20 years...
  16. ncbi request reprint Long-term follow-up of Philadelphia chromosome-positive (Ph) chronic myeloid leukaemia (CML) in children and adolescents managed at a single institution over a 20-year period
    Fiorina Giona
    Br J Haematol 130:970-2. 2005